Brain metastases

Neurologic Clinics

Volumn 21, Issue 1, 2003, Pages 1-23

  Lassman, Andrew B ^a   DeAngelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN HERNIA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; STEREOTAXIC SURGERY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; COGNITION DISORDERS; COLORECTAL NEOPLASMS; HUMANS; INTRACRANIAL PRESSURE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; SEIZURES; THYROID NEOPLASMS;

EID: 0037309783     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00035-X     Document Type: Review

References (119)

1. Gowers WR. A manual of diseases of the nervous system. Philadelphia: P. Blakiston, So & Co.; 1888. p. 904.
2. Walker AE, Robbins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985;35:219-26.
3. Baker AB. Metastatic tumors of the nervous system. Arch Pathol 1942;24:495-537.
4. Globus JH, Meltzer T. Metastatic tumors of the brain. Arch Neurol Psychiatr 1942; 482:163-226.
5. Tom MI. Metastatic tumours of the brain. Can Med Assoc J 1946;54:265-8.
6. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 1950;3:74-85.
7. Chason JL, Walker FB, Landers JW. Metastatic carcinoma in the central nervous system and dorsal root ganglia. A prospective autopsy study. Cancer 1963;16:781-7.
8. Hunter KM, Rewcastle NB. Metastatic neoplasms of the brainstem. Can Med Assoc J 1968;98:1-7.
9. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol 1978;19:589-92.
10. Zimm S, Wampler GL, Stablein D, et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981;48:384-94.
11. Lagerwaard FJ, Levendag PC, Nowak PJ, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;434:795-803.
12. Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastases. Histology, multiplicity, surgery and survival. Cancer 1996;78:1781-8.
13. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic Cranial Irradiation Overview Collaborative Group. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999;12:476-84.
14. Lassen U, Daugaard G, Eigtved A, et al. 18F-FDG positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 1999;35:1076-82.
15. King AB, Ford FR. A clinical and anatomical study of neurological conditions resulting from metastases in the central nervous system due to carcinoma of the lung: review of 100 cases. Bull Johns Hopkins Hosp 1942;70:124-56.
16. Ewing J. Neoplastic diseases: a treatise on tumors. 3rd edition. Philadelphia: W.B. Saunders; 1928. p. 77-89.
17. Hwang TL, Close TP, Grego JM, et al. Predilection of brain metastasis in grey and white matter junction and vascular border zones. Cancer 1996;77:1551-5.
18. Graeber MC, Jordan E, Mishra SK, et al. Watershed infarction on computed tomographic scan - an unreliable sign of hemodynamic stroke. Arch Neurol 1992;49:311-3.
19. Delattre JY, Krol G, Thaler HT, et al. Distribution of brain metastases. Arch Neurol 1988;45:741-4.
20. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
21. Mandybur TI. Intracranial hemorrhage caused by metastatic tumors. Neurology 1977; 27:650-5.
22. Byrne TN, Cascino TL, Posner JB. Brain metastases from melanoma. J Neurooncol 1983;1:313-7.
23. Forsythe PA. Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology 1993;43:1678-83.
24. Pepin EP. Cerebral metastasis presenting as migraine with aura. Lancet 1990;336: 127-8.
25. Posner JB. Diagnosis and treatment of metastases to the brain. Clin Bull 1974;4:47-57.
26. Berry HC, Parker RG, Gerdes AJ. Irradiation of brain metastases. Acta Radiol 1974; 13:535-44.
27. Posner JB. Brain metastases: 1995, a brief review. J Neurooncol 1996;27:287-93.
28. Lewis I. Chorea: an unusual manifestation of cerebral metastases. Neurology 1968;18: 948-952.
29. Sze G, Shin BA, Krol G, et al. Intraparenchymal brain metastases: MR imaging versus contrast-enhanced CT. Radiology 1988;168:187-94.
30. Davis PC, Hudgins PA, Peterman SB, et al. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast enhanced MR imaging. Am J Neuroradiol 1991;12:293-300.
31. Sze G, Milano E, Johnson C, et al. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. Am J Neuroradiol 1990; 11:785-91.
32. Schaefer PW, Budzik RF, Gonzalez RG. Imaging of cerebral metastases. Neurosurg Clin North Am 1996;7:393-423.
33. Nemzek W, Poirier V, Slamat MS, et al. Carcinomatous encephalitis (military metastases): lack of contrast enhancement. Am J Neuroradiol 1993;14:540-2.
34. Weaver S, Rosenblum MK, DeAngelis LD. Herpes varizella zoster encephalitis in immunocompromised patients. Neurology 1999;52:193-5.
35. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500.
36. Masdeu JC, Moreira J, Trasi S, et al. The open ring. A new imaging sign in demyelinating disease. J Neuroimaging 1996;6:104-7.
37. Doyle WK, Budinger TF, Valk PE, et al. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 1987;11:563-70.
38. Plum F, Posner JB. The diagnosis of stupor and coma. 3rd edition. Philadelphia: F.A. Davis; 1980.
39. Karnofsky DA, Abelmann WH, Craver LF, et al. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-56.
40. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 199-205.
41. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
42. Ruderman NB, Hall TC. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 1965;18:298-306.
43. Weinstein JD, Toy FJ, Jaffe ME, et al. The effect of dexamethasone on brain edema in patients with metastatic brain tumors. Neurology 1973;23:121-9.
44. Fadul CE, Lemann W, Thaler HT, et al. Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology 1988;38:348-52.
45. Posner JB. Neurologic complications of cancer. Philadelphia: F.A. Davis; 1995. p. 158.
46. Batchelor TT, Taylor LP, Thaler HT, et al. Steroid myopathy in cancer patients. Neurology 1997;48:1234-8.
47. Marshall RS, Mayer SA. On call neurology. Philadelphia: W.B. Saunders; 1997. p. 77, 154-164.
48. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54: 1886-93.
49. Fetell MR, Grossman SA, Fisher JD, et al. Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium. J Clin Oncol 1997;15: 3121-3128.
50. Delattre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988;38:194-8.
51. Hoang-Xuan K, Delattre JY, Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology 1990;40:1144-5.
52. Markesbery WR, Brooks WH, Gupta GD, et al. Treatment for patients with cerebral metastases. Arch Neurol 1978;35:754-6.
53. Amer MH, Al-Sarraf M, Baker LH, et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978;42:660-8.
54. Loeffler JS, Kooy HM, Wen PY, et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 1990;8:576-82.
55. Distefano A, Yap Y, Hortobagyi GN. The natural history of breast cancer patients with brain metastases. Cancer 1979;44:1913-8.
56. Maor MH, Frias AE, Oswald MJ. Palliative radiotherapy for brain metastases in renal cell carcinoma. Cancer 1988;62:1912-7.
57. Cascino TL, Leavengood JM, Kemeny N, et al. Brain metastases from colon cancer. J Neurooncol 1983;1:203-9.
58. Chao JH, Phillips R, Nickson JJ. Roentgen-ray therapy of cerebral metastases. Cancer 1954;7:682-9.
59. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1981;7:1633-8.
60. Borgelt B, Gelber R, Larson M, et al. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1980;6:1-9.
61. Epstein BE, Scott CB, Sause WT, et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Cancer 1993;71:1362-7.
62. Sause WT, Scott C, Krisch R, et al. Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys 1993;26:P653-657.
63. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the radiation therapy oncology group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-4.
64. Aiken R, Leavengood JM, Kim JH, et al. Metronidazole in the treatment of metastatic brain tumors. J Neurooncol 1984;2:105-11.
65. Komarnicky LT, Phillips T, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991;20:53-58.
66. DeAngelis LM, Currie VE, Krol G, et al. The combined use of radiation therapy and Ionidamine in the treatment of brain metastases. J Neurooncol 1989;7:241-7.
67. Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastases. Ann Neurol 1980;7:529-41.
68. Carella RJ, Gelber R, Hendrickson F, et al. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Radiation therapy oncology group brain metastases study I and II. Cancer 1980;45:679-83.
69. Cairncross JG, Chernik NL, Kim JH, et al. Sterilization of cerebral metastases by radiation therapy. Neurology 1979;29:1195-202.
70. Patchell RA, Cirrincione C, Thaler HT, et al. Single brain metastases: surgery plus radiation or radiation alone. Neurology 1986;36:447-53.
71. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993;33:583-90.
72. Noordijk EM, Vecht C, Haaxma-Reiche H, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994;29:711-7.
73. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;78:1470-6.
74. Bindal RK, Sawaya R, Leavens ME, et al. Surgical treatment of multiple brain metastases. J Neurosurg 1993;79:210-6.
75. Sundaresan N, Sachdev VP, DiGiacinto GV, et al. Reoperation for brain metastases. J Clin Oncol 1988;6:1625-9.
76. Bindal RK, Sawaya R, Leavens ME, et al. Reoperation for recurrent metastatic brain tumors. J Neurosurg 1995;83:600-4.
77. Kurup P, Reddy S, Hendrickson FR. Result of re-irradiation for cerebral metastases. Cancer 1980;46:2587-9.
78. Hazuka MB, Kinzie JJ. Brain metastases: results and effects of re-irradiation, Int J Radiat Oncol Biol Phys 1988;15:433-7.
79. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998;280:1485-9.
80. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-96.
81. Grau JJ, Verger E, Brandes AA, et al. Radiotherapy of the brain in elderly patients. Eur J Cancer 2000;36:451-2.
82. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-9.
83. Boyd TS, Mehta MP. Stereotactic radiosurgery for brain metastases. Oncology 1999;13:1397-409.
84. Huang CF, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for brainstem metastases. J Neurosurg 1999;91:563-8.
85. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291-8.
86. Noel G, Proudhom MA, Valery CA, et al. Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol 2001;60:61-7.
87. Sanghavi SN, Saranarenda S, Miranpuri BS, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001;51:426-34.
88. Flickinger JC, Kondziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastases. Int J Radiat Oncol Biol Phys 1994;28:797-802.
89. Bindal AK, Bindal RK, Hess K, et al. Surgery versus radiosurgery in the treatment of brain metastases. J Neurosurg 1996;84:748-54.
90. Aucher RM, Lamond JP, Alexander E, et al. A mutli-institutional outcome and prognostic factor analysis of radiosurgery for respectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35.
91. Shirato H, Takamura A, Tomita M, et al. Stereotactic irradiation without whole-brain irradiation for single brain metastases. Int J Radiat Oncol Biol Phys 1997;37:385-91.
92. Sneed PN, Lamborn KR, Forstner JM, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999;43:549-58.
93. Fuller BG, Kaplan ID, Adler J, et al. Stereotaxic radiosurgery for brain metastases: the importance of adjuvant brain irradiation. Int J Radiat Oncol Biol Phys 1992;23:413-8.
94. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with wholebrain radiotherapy for brain metastases. J Clin Oncol 1998;16:3563-9.
95. Joseph J, Adler JR, Cox RS, et al. Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 1996;14:1085-92.
96. Buckner JC. The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Cancer Metastasis Rev 1991;19:335-41.
97. Lester SG, Morphis JG, Hornback NB, et al. Brain metastases and testicular tumors: need for aggressive therapy. J Clin Oncol 1984;2:1397-403.
98. Kristensen CA, Kristjansen PEG, Hansen HH. Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J Clin Oncol 1992;10:1498-502.
99. Postmus PE, Smit EF. Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 1999;10:753-9.
100. Lee JS, Murphy WK, Glisson BS, et al. Primary chemotherapy of brain metastases in small-cell lung cancer. J Clin Oncol 1989;7:916-22.
101. Postmus PE, Haaxma-Reiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy: a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000;18:3400-8.
102. Boogerd W, van der Sande JJ, van Zandwijk N. Teniposide sometimes effective in brain metastases from non-small cell lung cancer. J Neurooncol 1999;41:285-9.
103. Franciosi V, Cocconi G, Michiara M, et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, non-small cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 1999;85:1599-1605.
104. Abrey LE, Olson JD, Raizer JJ, et al. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 2001;53:259-65.
105. Biasco G, Pantaleo MA, Casadei S. treatment of brain metastases of malignant melanoma with temozolomide. N Engl J Med 2001;345:621-2.
106. Fujita A, Takabatake H, Tagaki S, et al. Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer. Oncology 2000;59:105-9.
107. Fujita A, Fukuoka S, Takabatake H, et al. Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer. Oncology 2000;59:291-5.
108. Rosner D, Nemoto T, Lane WW. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986;58:832-9.
109. Boogerd W, Dalesio O, Bais EM, et al. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992;69:972-80.
110. Cocconi G, Lottici R, Bisagni G, et al. Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer Invest 1990;8:327-34.
111. Colleoni M, Craiff C, Nelli P, et al. Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma. Am J Clin Oncol 1997;203:303-7.
112. Salvati M, Cervoni L, Innocenzi G, et al. Prolonged stabilization of multiple and single brain metastases from breast cancer with tamoxifen. Report of three cases. Tumori 1993;79:359-82.
113. Pors H, von Eyben FE, Sorensen OS, et al. Long term remission of multiple brain metastases with tamoxifen. J Neurooncol 1991;10:173-7.
114. Carey RW, Davis JM, Zervas NT. Tamoxifen-induced regression of cerebral metastases in breast carcinoma. Cancer Treat Rep 1981;65:793-5.
115. van der Gaast A, Alexieva-Figusch J, Verweij J, et al. Complete remission of brain metastasis to third-line hormonal treatment with megestrol acetate. Am J Clin Oncol 1990;13:507-9.
116. Lissoni P, Barni S, Ardizzoia A, et al. A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer 1994;73:699-701.
117. Weed JC, Hunter VH. Diagnosis and management of brain metastases from gestational trophoblastic disease. Oncology 1991;5:48-9.
118. Rustin GJ, Newlands ES, Begent RHJ, et al. Weekly alternating etoposide, methotrexate, and actinomycin/Vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 7:900-3.
119. Lassman AB, Abrey LE, Begemann M, et al. Systemic high dose methotrexate (HD MTX) for central nervous system (CNS) metastases [abstract]. In: Proceedings of the Amer Soc Clin Oncol 2002;21(part 2 of 2):2083.